Cargando…

Mammalian Target of Rapamycin: Hitting the Bull's-Eye for Neurological Disorders

The mammalian target of rapamycin (mTOR) and its associated cell signaling pathways have garnered significant attention for their roles in cell biology and oncology. Interestingly,the explosion of information in this field has linked mTOR to neurological diseases with promising initial studies. mTOR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chong, Zhao Zhong, Shang, Yan Chen, Zhang, Lijie, Wang, Shaohui, Maiese, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154047/ https://www.ncbi.nlm.nih.gov/pubmed/21307646 http://dx.doi.org/10.4161/oxim.3.6.14787

Ejemplares similares

Mammalian target of rapamycin signaling in diabetic cardiovascular disease
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Driving neural regeneration through the mammalian target of rapamycin
por: Maiese, Kenneth
Publicado: (2014)

Effective Aid for Hitting the Bull’s Eye: Comment on "It’s About the Idea Hitting the Bull’s Eye": How Aid Effectiveness Can Catalyse the Scale-up of Health Innovations"
por: Beracochea, Elvira
Publicado: (2018)

Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma
por: Yeo, Dannel, et al.
Publicado: (2021)

The Mechanistic Target of Rapamycin (mTOR): Novel Considerations as an Antiviral Treatment
por: Maiese, Kenneth
Publicado: (2020)

Autism Spectrum Disorder and Mammalian Target of Rapamycin System
por: Posar, Annio, et al.
Publicado: (2020)

Prevention of β-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL
por: Shang, Yan Chen, et al.
Publicado: (2012)

PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
por: Chong, Zhao Zhong, et al.
Publicado: (2012)

Erythropoietin: New Directions for the Nervous System
por: Maiese, Kenneth, et al.
Publicado: (2012)

Oxidant Stress and Signal Transduction in the Nervous System with the PI 3-K, Akt, and mTOR Cascade
por: Maiese, Kenneth, et al.
Publicado: (2012)

Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways
por: Chong, Zhao Zhong, et al.
Publicado: (2010)

Hitting the Bull’s-Eye in Metastatic Cancers—NSAIDs Elevate ROS in Mitochondria, Inducing Malignant Cell Death
por: Ralph, Stephen John, et al.
Publicado: (2015)

Impacting dementia and cognitive loss with innovative strategies: mechanistic target of rapamycin, clock genes, circular non-coding ribonucleic acids, and Rho/Rock
por: Maiese, Kenneth
Publicado: (2019)

Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
por: Groenewoud, Marlous J., et al.
Publicado: (2013)

Crosstalk of the Caspase Family and Mammalian Target of Rapamycin Signaling
por: Yan, Junfang, et al.
Publicado: (2021)

Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment
por: Martelli, Alberto M., et al.
Publicado: (2012)

Regional analgesia technique for postoperative analgesia in total knee arthroplasty: have we hit the bull’s eye yet?
por: Sonawane, Kartik, et al.
Publicado: (2021)

SIRT1 Negatively Regulates the Mammalian Target of Rapamycin
por: Ghosh, Hiyaa Singhee, et al.
Publicado: (2010)

Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2011)

Therapeutic control of leishmaniasis by inhibitors of the mammalian target of rapamycin
por: Khadir, Fatemeh, et al.
Publicado: (2018)

"It’s About the Idea Hitting the Bull’s Eye": How Aid Effectiveness Can Catalyse the Scale-up of Health Innovations
por: Wickremasinghe, Deepthi, et al.
Publicado: (2018)

Hitting the bull’s eye of ending tuberculosis goal: The challenge of addressing tuberculosis in human immunodeficiency virus positive population in India
por: Dabla, Vandana
Publicado: (2019)

Inhibition of mammalian target of rapamycin by rapamycin increases the radiosensitivity of esophageal carcinoma Eca109 cells
por: ZHANG, DEJUN, et al.
Publicado: (2014)

Prospects and hot spots for mammalian target of rapamycin in the field of neuroscience from 2002 to 2021
por: Li, Lijun, et al.
Publicado: (2022)

Activated mammalian target of rapamycin is a potential therapeutic target in gastric cancer
por: Xu, Da-zhi, et al.
Publicado: (2010)

Mammalian Tribbles Homologs at the Crossroads of Endoplasmic Reticulum Stress and Mammalian Target of Rapamycin Pathways
por: Cunard, Robyn
Publicado: (2013)

Building the immunological bull's eye
por: Robinson, Richard
Publicado: (2007)

Mammalian target of rapamycin and head and neck squamous cell carcinoma
por: Liao, Yu-Min, et al.
Publicado: (2011)

New Developments in Mammalian Target of Rapamycin Inhibitors for the Treatment of Sarcoma
por: Agulnik, Mark
Publicado: (2012)

Retraction: Mammalian target of rapamycin inhibitors for treatment in tuberous sclerosis
por: Kim, Won Seop
Publicado: (2013)

The cytotoxic T cell proteome and its shaping by mammalian Target of Rapamycin
por: Hukelmann, Jens L., et al.
Publicado: (2015)

The Role of Mammalian Target of Rapamycin (mTOR) in Insulin Signaling
por: Yoon, Mee-Sup
Publicado: (2017)

The Role of the Mammalian Target of Rapamycin (mTOR) in Pulmonary Fibrosis
por: Lawrence, Jessica, et al.
Publicado: (2018)

Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation
por: Leal, Rita, et al.
Publicado: (2017)

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
por: Querfurth, Henry, et al.
Publicado: (2021)

Combining the mammalian target of rapamycin inhibitor, rapamycin, with resveratrol has a synergistic effect in multiple myeloma
por: Jin, Hong-Guang, et al.
Publicado: (2018)

Rapamycin protects against aristolochic acid nephropathy in mice by potentiating mammalian target of rapamycin-mediated autophagy
por: Lin, Fan, et al.
Publicado: (2021)

Inhibition of mammalian target of rapamycin improves neurobehavioral deficit and modulates immune response after intracerebral hemorrhage in rat
por: Lu, Qin, et al.
Publicado: (2014)

Functional interaction of mammalian target of rapamycin complexes in regulating mammalian cell size and cell cycle
por: Rosner, Margit, et al.
Publicado: (2009)

Prognostic significance and function of mammalian target of rapamycin in tongue squamous cell carcinoma
por: Li, Shau-Hsuan, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ttr5b11fhosb9him3rrnkdateq